Capricor Therapeutics, Inc. (CAPR)

NASDAQ: CAPR · Real-Time Price · USD

27.87

-0.64 (-2.24%)

At close: Feb 23, 2026, 4:00 PM EST

28.62

+0.75 (2.69%)

Pre-market: Feb 24, 2026, 4:34 AM EST

Capricor Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 23, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,441	627	151	97	71	70
Market Cap Growth	121.21%	316.72%	54.55%	37.70%	0.89%	1046.92%
Enterprise Value	1,357	544	124	54	30	35
Last Close Price	27.87	13.80	4.89	3.86	2.93	3.43
PS Ratio	129.50	28.18	5.98	38.19	288.92	226.06
PB Ratio	15.19	4.31	6.66	8.27	2.26	2.49
P/TBV Ratio	17.19	4.31	6.66	8.27	2.26	2.49
P/FCF Ratio	-	-	-	62.58	-	-
P/OCF Ratio	-	-	-	19.82	-	-
EV/Sales Ratio	121.95	24.43	4.94	21.01	122.30	113.31
EV/FCF Ratio	-	-	-	34.43	-	-
Debt / Equity Ratio	0.17	0.01	0.10	0.22	0.09	0.01
Debt / FCF Ratio	-	-	-	1.64	-	-
Net Debt / Equity Ratio	-1.00	-1.03	-1.65	-3.30	-1.02	-1.15
Net Debt / EBITDA Ratio	0.99	3.65	1.62	1.33	1.55	2.39
Net Debt / FCF Ratio	1.23	3.61	1.35	-24.96	1.78	3.05
Asset Turnover	0.10	0.19	0.46	0.06	0.01	0.01
Quick Ratio	3.50	7.70	1.59	1.78	8.54	11.01
Current Ratio	3.59	7.77	1.63	1.82	8.82	11.33
Return on Equity (ROE)	-107.79%	-48.16%	-129.63%	-134.49%	-67.23%	-77.95%
Return on Assets (ROA)	-49.39%	-23.21%	-27.66%	-40.60%	-34.46%	-37.42%
Return on Capital Employed (ROCE)	-88.20%	-28.50%	-87.70%	-112.00%	-56.30%	-43.30%
Earnings Yield	-5.69%	-6.45%	-14.80%	-29.78%	-28.30%	-19.47%
FCF Yield	-4.74%	-6.62%	-18.36%	1.60%	-25.45%	-15.12%
Buyback Yield / Dilution	-43.02%	-31.52%	-9.06%	-6.34%	-48.28%	-319.55%

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q